Naradja Wissmar: Raised IL-32 as a Hint to Long-Term Immune Activation Post-COVID
Naradja Wissmar, Former Administrator at Karolinska Institute, shared on LinkedIn:
”University of Milan teams found SARS-CoV-2 exposure raised blood IL 32, an inflammatory cytokine, and levels stayed high at least 1 year after severe COVID 19, hinting at lingering immune activation and a biomarker for long term effects.”
Title: Association of SARS-CoV-2 infection with long-lasting increase in circulating IL-32 levels
Authors: Lorenzo Miano, Elena Sinopoli, Alessandro Cherubini, Chiara Suffritti, Serena Pelusi, Fatima Rahmeh, Giuseppe Enzo Lamorte, Flora Peyvandi, Francesco Blasi, Giacomo Grasselli, Alessandra Bandera, Roberta Gualtierotti, Daniele Prati, Luca Vittorio Carlo Valenti
Read the Full Article on Frontiers
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 1, 2026, 11:10Mehran Ghasemzadeh: A Novel Panel Bridging Platelet Function and Clinical Presentation in Chronic ITP
-
Mar 1, 2026, 10:47Tagreed Alkaltham: In Transfusion Medicine, Every Reaction Deserves An Answer
-
Mar 1, 2026, 10:31Deborah Siegal Explores ARTESiA in The CLOT Conversation’s Latest Episode
-
Mar 1, 2026, 09:46Jecko Thachil: Tackling the Balance Between Bleeding and Thrombosis in CKD
-
Mar 1, 2026, 09:35Emmanuel J Favaloro: When Tallied Together, Rare Bleeding Disorders Are Not So Rare
-
Mar 1, 2026, 09:10Satyam Arora: A Key Gap In Standardized Protocols for Pediatric Massive Transfusion
-
Mar 1, 2026, 08:46Heghine Khachatryan: The Future of Anticoagulation Beyond DOACs
-
Mar 1, 2026, 05:44Ilenia Calcaterra: Innovation In Rare Diseases Is Never Abstract
-
Feb 28, 2026, 17:03Investing in Education, Prevention, and Lifesaving Research for a Healthier Tomorrow – AHA